Showing results 1 to 1 of 1
| Issue Date | Title | Journal Title |
|---|---|---|
| 2026 | Amivantamab plus chemotherapy versus chemotherapy for first-line treatment of participants with EGFR exon 20 insertion-mutated advanced non-small cell lung cancer: PAPILLON Asia subgroup analysis | LUNG CANCER |